IP latest news (IPO) - The Share Centre

Please remember: Our website can help you make informed decisions, not provide personalised advice. If your investments fall in value, you could lose money.
Tax allowances and the benefits of tax-efficient accounts could change.

IP Group latest news (IPO)

» deal in this share

ISA Eligible

Latest ShareCast News

IP Group's Autifony Therapeutics agrees collaboration with Boehringer Ingelheim

By Oliver Haill

Date: Monday 18 Dec 2017

(ShareCast News) - Autifony Therapeutics, a spin-out from GlaxoSmithKline backed by IP Group, has signed a €627.5m central nervous system collaboration with German drugs giant Boehringer Ingelheim.

Regulatory News

Holding(s) in Company 17-Jan-2018 11:53 RNS
Holding(s) in Company 10-Jan-2018 09:12 RNS
Total Voting Rights 02-Jan-2018 07:00 RNS
Autifony signs Eur627.5m agreement with BI 18-Dec-2017 10:15 RNS
Diurnal receives positive CHMP opinion for Alkindi 15-Dec-2017 12:50 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.